Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.33 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL198668 | 0.80 | UGT2B7 (0.36) | UGT2B7LMNAKDM4E | |
| SCHEMBL3245690 | 0.78 | TSHR (0.37) | CYP2D6KDM4E | |
| SCHEMBL3248018 | 0.78 | CYP3A4 (0.30) | CYP2D6 | |
| SCHEMBL3240095 | 0.77 | SMN1; SMN2 (0.35) | KMT2AADRA2ACYP2D6LMNAKDM4E | |
| SCHEMBL6038386 | 0.77 | HTR2A (0.35) | UGT2B7 | |
| SCHEMBL6887508 | 0.77 | UGT2B7 (0.31) | UGT2B7 | |
| SCHEMBL295332 | 0.77 | UGT2B7 (0.31) | UGT2B7 | |
| SCHEMBL6896467 | 0.76 | — | — | |
| SCHEMBL2502578 | 0.74 | TSHR (0.37) | — | |
| SCHEMBL2498027 | 0.74 | CYP1A2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787757-B2 | Phenol derivative, and preparation process and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-10-17 | — | — | US | disclosed |
| CN-111056923-A | Phenol derivative and preparation method and application thereof | 中国石油化工股份有限公司 | 2020-04-24 | — | — | CN | disclosed |
| WO-2010002802-A1 | PYRROLIDINE-SUBSTITUTED AZAINDOLE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-01-07 | — | — | WO | disclosed |
| US-4010033-A | PHOTOCHROMIC SPIROPYRANE, NITROGEN-CONTAINING THIOETHER | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787757-B2 | Phenol derivative, and preparation process and use thereof | PTGES, PPARG, PTGES3 | TYR 258/4885UGT2B7 839/4885KMT2A 3928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.